Discovery and validation of molecular biomarkers contributing to the risk of coronary artery disease
Nutrition, Metabolism and Cardiovascular Diseases · 2026-09 · 36 (9) · 104759
DOI: 10.1016/j.numecd.2026.104759 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-09. Verfasst von Majid Nikpay. Beteiligte Einrichtung: Omics and Biomedical Analysis Core Facility, University of Ottawa Heart Institute, Ottawa, K1Y 4W7, Canada. Electronic address: mnikpay@ottawaheart.c…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alliance de recherche numérique du Canada.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Omics and Biomedical Analysis Core Facility, University of Ottawa Heart Institute, Ottawa, K1Y 4W7, Canada. Electronic address: mnikpay@ottawaheart.ca.
Förderung
- Alliance de recherche numérique du Canada
Zitieren
APA
Nikpay, M. (2026). Discovery and validation of molecular biomarkers contributing to the risk of coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases, 36(9), 104759. https://doi.org/10.1016/j.numecd.2026.104759
Vancouver
Nikpay M. Discovery and validation of molecular biomarkers contributing to the risk of coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(9):104759. doi:10.1016/j.numecd.2026.104759
BibTeX
@article{Nikpay2026,
author = {Nikpay, Majid},
title = {Discovery and validation of molecular biomarkers contributing to the risk of coronary artery disease},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {9},
pages = {104759},
doi = {10.1016/j.numecd.2026.104759}
}
EUVIMED